GHOST TREE CAPITAL LLC Overview

Ghost Tree Capital Llc is a hedge fund that manages 258 MM dollars in regulatory AUM and has 6 employees, of which 5 perform investment advisory functions.

The manager's has disclosed holdings from 12/31/13 to 09/30/16. The fund's latest filing disclosed 347MM in positions, representing 134% of the manager's regulatory AUM.

GHOST TREE CAPITAL LLC StockAlpha

+0.8%
Top 25%
3yr StockAlpha Register for more...

Fundamental & Technical Factor Exposure

Market Cap Beta Volatility
Momentum (12M) Momentum (6M) Momentum (3M)
Price/Book Price/Earnings Price/Cash Flow
Dividend Yield Sales Growth Earnings Growth
ROE ROA ROC
EBIDTA Margin Debt/Assets Hedge Fund Crowding

GHOST TREE CAPITAL LLC Since Last Filing Return Details

Ticker Size Sector Stock Move StockAlpha Attribution Days to Liquidate Trade Crowdedness
CLVS 5.2% Health 3.3% 0.56% 0 3%
ZBH 4.69% Health -21.99% -0.81% 0 13%
Get the Full Report
FEATURED IN
Logo of CNBC
Wall Street Journal Logo
Pensions & Investments logo
BloomBerg Logo

GHOST TREE CAPITAL LLC Founders and Key Employees

Name Title In Position Since
David Y. Kim Portfolio Manager, Managing Member February-2013
Christine J. Lay Member February-2013
Brian J. Tsai Chief Financial Officer, Chief Operating Officer And Chief Compliance Officer September-2014

GHOST TREE CAPITAL LLC Brokers, Custodians, Auditors and Administrators

Type Company
Administrator Pro
Auditor Pro
Auditor Pro
Custodian Pro
Custodian Pro
Prime Broker Pro
Prime Broker Pro

GHOST TREE CAPITAL LLC Investment Strategy

Methods of Analysis, Investment Strategies and Risk of Loss

Methods of Analysis and Investment Strategies Generally

Ghost Tree’s research process is focused on forming differentiated views and unique insights into critical value drivers that impact individual companies, competitive markets, therapeutic categories and the broader healthcare industry, in order to attempt to identify compelling investments for the Funds. Areas of research may include the following:

1) Technological innovation and obsolescence among medical device and drug manufacturers;
2) Unsatisfied medical needs and emerging novel therapies;
3) Early stage biotechnology developments and clinical trial analysis;
4) Regulatory changes and healthcare reform;
5) Patent issuances and intellectual property disputes;
6) Reimbursement policies and pricing changes;
7) Operational turnarounds and balance sheet allocation strategies; and
8) Industry co...
Get the Full Report

GHOST TREE CAPITAL LLC Portfolio Concentration

GHOST TREE CAPITAL LLC Location

150 EAST 52ND ST.
SUITE 17001
NEW YORK, New York
UNITED STATES, 10022

GHOST TREE CAPITAL LLC Contact Information

Phone Number: 646-779-0120
Fax Number: DECEMBER
Website:

READ RECENT SYMMETRIC REPORTS

Disclaimer

The information contained herein: (1) is proprietary to Symmetric and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Symmetric nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance and skill metrics are no guarantee of future results. "Symmetric," "Symmetric.io" and the Symmetric logo are marks of Symmetric, Inc. Read our privacy policy here. Read our terms of use here
Path B